[1] [23] Your doctor should review important safety information with you, including the boxed warning regarding thyroid C-cell tumors and contraindications for patients with personal/family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2
Before starting treatment, baseline tests should be conducted to establish a clear picture of the patients health
Test characteristics Species Human Sample types Serum and EDTA plasma Sample volume 25 L Assay range 0.9 - 940 pmol/L (2.8 - 2940 pg/mL) Detection limit 0.65 pmol/L Incubation 2h + 15 min Detection method Chemiluminescence specificity The following cross-reactions have been tested: GLP-1 (1-36) amide 88% GLP-1 (7-36) amide 93% GLP-1 (9-36) amide 100% GLP-1 (1-37) Not detected GLP-1 (7-37) Not detected Glucagon Not detected GIP Not detected GLP-2 Not detected Oxyntomodulin Not detected Glicentin Not detected Miniglucagon Not detected MPGF Not detected Liraglutide Not detected Exenatide Not detected Lixisenatide Not detected Dulaglutide 0.07% directions for use Certificate of Analysis directions for use Certificate of Analysis SAFETY DATA SHEET technical notes For technical notes specific to Mercodia Total GLP-1 ELISA see: TN34-0154 Sample collection and handling for Mercodia Total GLP-1 ELISA (10-1278-01) references Stinson, S
PlexusDx also offers Oral Semaglutide (at $289/mo month-to-month, or from $249/mo on the 6-month plan) and Oral Tirzepatide (at $349/mo month-to-month, or from $279/mo on the 6-month plan) for patients who prefer tablets, plus the Microdose GLP-1 Protocol at $129/mo flat for those seeking a gentler starting point
The high cost of anti-obesity medications, especially out-of-pocket, is a major barrier that may discourage patients from receiving or adhering to the aggressive treatment that the American Academy of Pediatrics recommends. In a probability sensitivity analysis using a willingness-to-pay threshold of $100,000 per QALYs gained, lifestyle counseling was the preferred strategy 100% of the time at 13 months and 81.3% of the time at 2 years
A low dose (1/4 of starting dose for weight loss) put my BN in remission after 22 years of failed interventions
